Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma

Nature Immunology

Volumn 1, Issue 3, 2000, Pages 221-226

  Karp, Christopher L ^a   Grupe, Andrew ^b   Schadt, Eric ^b   Ewart, Susan L ^c   Keane Moore, Michelle ^d   Cuomo, Peter J ^a   Köhl, Jörg ^e   Wahl, Larry ^f   Kuperman, Douglas ^d   Germer, Soren ^g   Aud, Dee ^b   Peltz, Gary ^b   Wills Karp, Marsha ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d The Johns Hopkins University   (United States)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^g ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; INTERLEUKIN 12;

AKR MOUSE; ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DNA MICROARRAY; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MONOCYTE; MOUSE; PERITONEUM MACROPHAGE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ASTHMA; CELLS, CULTURED; COMPLEMENT C5; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 5944254200     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/79759     Document Type: Article

References (42)

1. Evans, R. D. et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965-1984. Chest 91, 65S-74S (1987).
2. Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281 (1999).
3. Daniels, S. E. et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 383, 247-250 (1996).
4. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nature Genet 15, 389-392 (1997).
5. Ober, C. et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum. Mol. Genet. 7, 1393-1398 (1998).
6. Wjst, M. et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 58, 1-8 (1999).
7. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998).
8. Gavett, S.H. et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527-1536 (1995).
9. Keane-Myers, A., Wysocka, M., Trinchieri, G. & Wills-Karp, M. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J. Immunol. 161, 919-926 (1998).
10. Ewart, S. E. et al. Identification of quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am. J. Resp. Cell. Molec. Biol.
11. Wetsel, R. A., Fleischer, D. T. & Haviland, D. L. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265, 2435-2440 (1990).
12. Polorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
13. Vogel, S. N. et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an lpsn gene: In vivo evidence for a dominant negative mutation. J. Immunol. 162, 5666-5670 (1999).
14. Johnson, E. & Hetland, G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand. J. Immunol. 27, 489-493 (1988).
15. Hindmarsh, E. J. & Marks, R. M. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J. Immunol. 160, 6128-6136 (1998).
16. Wozencraft, A. O., Sayers, G. & Blackwell, J. M. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J. Exp. Med. 164, 1332-1337 (1986).
17. Bergh, K. & Iversen, O. J. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma. J. Immunol. Methods 152, 79-87 (1992).
18. Heller, T. et al. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163, 985-994 (1999).
19. Hong, K., Kinoshita, T., Miyazaki, W., Izawa, T. & Inoue, K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J. Immunol. 122, 2418-2423 (1979).
20. Wittmann, M. et al. C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763-6769 (1999).
21. Braun, M. C., Lahey, E. & Kelsall, B. L. Selective suppression of IL-12 production by ehemoattractants. J. Immunol. 164, 3009-3017 (2000).
22. Gerard, C. & Gerard, N. P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808 (1994).
23. Loots, G. G. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136-140 (2000).
24. Fearon, D. T. The complement system and adaptive immunity. Semin. Immunol. 10, 355-361 (1998).
25. Mosser, D. M. & Karp, C. L. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11, 406-411 (1999).
26. Wang, C. et al. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood 85, 2570-2578 (1995).
27. Wang, C., Gerard, N.P. & Nicholson-Weller, A. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. J. Immunol. 156, 786-792 (1996).
28. Kilgore, K. S. et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κ B activation. Am. J. Pathol. 150, 2019-2031 (1997).
29. Morgan, E. L. et al. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937-3942 (1992).
30. Schindler, R., Gelfand, J. A. & Dinarello, C. A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76, 1631-1638 (1990).
31. Cavaillon, J. M., Fitting, C., Haeffner-Cavaillon, N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur. J. Immunol. 20, 253-257 (1990).
32. Sam, H. & Stevenson, M. M. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria. Clin. Exp. Immunol. 117, 343-349 (1999).
33. Wang, Y., Rollins, S. A., Madri, J. A. & Matis, L. A. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl Acad. Sci. USA 92, 8955-5959 (1995).
34. Tsuji, R. F. et al. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ a possible initiating role of B cells. J. Exp. Med. 186, 1015-1026 (1997).
35. Gervais, F., Stevenson, M. & Skamene, E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J. Immunol. 132, 2078-2083 (1984).
36. Barton, P. A. & Warren, J. S. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61, 1474-1481 (1993).
37. Trinchieri, G. Interleukin-12: a cytokine at the interfece of inflammation and immunity. Adv. Immunol. 70, 83-243 (1998).
38. Hopken, U. E., Lu, B., Gerard, N. P. & Gerard, C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186, 749-756 (1997).
39. van der Pouw Kraan, T. C. et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J. Immunol. 158, 5560-5565 (1997).
40. Naseer, T. et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit Care Med. 155, 845-351 (1997).
41. Germer, S., Holland, M. J. & Higuchi, R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10, 258-266 (2000).
42. Karp, C. L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231 (1996).